Table 7.

Adjusted mortality for confounders across pulmonary vascular resistance groups

	Adjusted for lung diseasea  n = 2873		Adjusted for heart diseasea  n = 2783		Adjusted for CTDa  n = 2929		Adjusted for lung and heart diseasea  n = 2736		Adjusted for all comorbiditiesa  n = 2736
	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value	HR (95% CI)	P-value
PVR >2–≤3 WU	1.28 (1.10–1.48)	.00108	1.44 (1.24–1.66)	.00000144	1.43 (1.24–1.65)	.00000129	1.28 (1.10–1.49)	.00119	1.28 (1.10–1.49)	.00147
PVR >3 WU	2.15 (1.89–2.45)	<.000001	2.54 (2.23–2.90)	<.000001	2.47 (2.18–2.81)	<.000001	2.22 (1.93–2.54)	<.000001	2.23 (1.95–2.55)	<.000001

^aAdjusted for age/sex.